59
|
353
|
5m32c |
Human 26s proteasome in complex with oprozomib |
40
|
203
|
5m32N |
Human 26s proteasome in complex with oprozomib |
44
|
230
|
5m32A |
Human 26s proteasome in complex with oprozomib |
39
|
233
|
5m32D |
Human 26s proteasome in complex with oprozomib |
43
|
221
|
5m32H |
Human 26s proteasome in complex with oprozomib |
62
|
211
|
5lttK |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
70
|
242
|
5lttD |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
18
|
205
|
5m32j |
Human 26s proteasome in complex with oprozomib |
4
|
26
|
5m32s |
Human 26s proteasome in complex with oprozomib |
46
|
342
|
5m32d |
Human 26s proteasome in complex with oprozomib |
51
|
301
|
5m32i |
Human 26s proteasome in complex with oprozomib |
64
|
231
|
5m2bE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
97
|
422
|
5m32l |
Human 26s proteasome in complex with oprozomib |
59
|
226
|
5m2bH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
63
|
241
|
5l6cG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
57
|
196
|
5l62N |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
61
|
222
|
5l63L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
69
|
244
|
5l63B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
58
|
226
|
5l64H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
67
|
211
|
5l60K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
67
|
233
|
5l60M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
64
|
231
|
5l65E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
61
|
195
|
5l5vJ |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
61
|
231
|
5l63E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
63
|
241
|
5l62G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
68
|
240
|
5l63C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
66
|
250
|
5l62A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
60
|
222
|
5l62L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
69
|
244
|
5l5xB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
68
|
233
|
5l62M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
65
|
233
|
5l5dM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
57
|
195
|
5l5wJ |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
65
|
250
|
5l61A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
59
|
196
|
5l63N |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
59
|
226
|
5l68H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
72
|
240
|
5l5xC |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
33
|
274
|
5m32q |
Human 26s proteasome in complex with oprozomib |
70
|
243
|
5l61F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
66
|
250
|
5l68A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
66
|
242
|
5l64D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
70
|
243
|
5l68F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
58
|
204
|
5l68I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
69
|
243
|
5l66F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
64
|
231
|
5l66E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
65
|
211
|
5l65K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
66
|
211
|
5l66K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
59
|
196
|
5l5iN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
59
|
196
|
5l67N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
63
|
241
|
5l5yG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
66
|
250
|
5l5uA |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |